Most of the existing studies showed that IL-6 levels were higher than normal ranges in COVID-19 patients [6,11,12]; also, IL-6 levels were greater in severe cases of COVID-19 than in mild to moderate forms [13,14], although it was unclear whether these cases corresponded to patients admitted to the ICU or just those suffering from moderate to severe lung involvement. This evidence concerns the gene IL6 and COVID-19.